Bristol Myers Squibb stock pre-market at EUR 54.91

Published on 10/26/2026 at 07:58 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

The pharmaceutical company develops medicines across multiple therapeutic areas. At Lang & Schwarz the stock trades pre-market at EUR 54.91 on October 26, 2026.

Business model and market

Bristol Myers Squibb develops biopharmaceutical medicines across several therapeutic areas.
The benchmark for the U.S. home market is the S&P 500.
Bristol Myers Squibb stock trades pre-market at EUR 54.91 at 7:54 a.m. CET at Lang & Schwarz on October 26, 2026.

Bristol Myers Squibb, US1101221083, Illustration mit AI erstellt.

Bristol Myers Squibb focuses on developing medicines in oncology, hematology, neuroscience, immunology and cardiovascular care, according to its investor page. The stock trades pre-market at EUR 54.91 at 7:54 a.m. CET at Lang & Schwarz on October 26, 2026.

Ahead of the Xetra open

The quote is available before the Xetra session begins. The further course from the Xetra open at 9:00 a.m. CET is shown by the continuously updated real-time quote of Bristol Myers Squibb stock.